Amerigo Scientific releases transglutaminase inhibitors designed to advance research into their therapeutic applications across a range of diseases. These transglutaminase inhibitors seek to enable ground-breaking findings in a number of domains, such as autoimmune illnesses, neurological diseases, and cancer research.
“We recognize the urgent need for effective research tools that...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek